Literature DB >> 30371624

Spectral Computed Tomography for the Quantitative Assessment of Patients With Carcinoma of the Gastroesophageal Junction: Initial Differentiation Between a Diagnosis of Squamous Cell Carcinoma and Adenocarcinoma.

Yue Zhou1, Ping Hou1, Kaiji Zha1, Dan Liu2, Feng Wang3, Kun Zhou4, Jianbo Gao1.   

Abstract

OBJECTIVE: This study aimed to distinguish between esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) using spectral computed tomography (CT) and to discuss the accuracy according to an optimal threshold of single and combined parameters.
METHODS: In this monoinstitution study, 61 patients, 35 of whom had ESCC and 26 had EAC confirmed by surgery or esophagoscopy, were recruited from August 2016 to March 2017. Enrolled patients underwent dual-phase chest CT enhancement. The spectral CT parameters (NIC, NICD, NICratio, Zeff, Zeff-C, K40-70 keV, K80-100 keV, and K110-140 keV) were measured during arterial phase (AP) and venous phase (VP). Binary logistic regression was used to calculate combined predictive probability. Thresholds of quantitative parameters and diagnostic accuracy were calculated using receiver operating characteristic curve.
RESULTS: Compared with ESCC, higher NICAP, NICVP, NICD, Zeff AP, Zeff VP, Zeff-C AP, and Zeff-C VP were observed for EAC, whereas NICratio was lower for EAC. Higher K40-70 keV, K80-100 keV, and K110-140 keV were exhibited in EAC than in ESCC. Area under the curve (AUC) of NICAP, K40-70 keV AP, and Zeff AP were 0.720, 0.730, and 0.706, respectively. The area under the curve of new combined predictive value of NICAP and λ40-0 keV AP was 0.804. The sensitivity and specificity were 77.80% and 80.60%, respectively, when the threshold of new predictive value was 0.60.
CONCLUSION: The diagnostic accuracy obtained by using NICAP and K40-70 keV AP combined is better than that obtained using a single parameter in differentiation between a diagnosis of squamous cell carcinoma and adenocarcinoma.

Entities:  

Mesh:

Year:  2019        PMID: 30371624     DOI: 10.1097/RCT.0000000000000826

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

1.  Prognostic value of pretreatment contrast-enhanced computed tomography in esophageal neuroendocrine carcinoma: A multi-center follow-up study.

Authors:  Yue Zhou; Ping Hou; Kai-Ji Zha; Feng Wang; Kun Zhou; Wei He; Jian-Bo Gao
Journal:  World J Gastroenterol       Date:  2020-08-21       Impact factor: 5.742

2.  Dual-layer dual-energy CT for improving differential diagnosis of squamous cell carcinoma from adenocarcinoma at gastroesophageal junction.

Authors:  Meihong Wu; Mao Sheng; Ruomei Li; Xinna Zhang; Xingbiao Chen; Yin Liu; Bin Liu; Yongqiang Yu; Xiaohu Li
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

3.  Application of computed tomography-based radiomics in differential diagnosis of adenocarcinoma and squamous cell carcinoma at the esophagogastric junction.

Authors:  Ke-Pu Du; Wen-Peng Huang; Si-Yun Liu; Yun-Jin Chen; Li-Ming Li; Xiao-Nan Liu; Yi-Jing Han; Yue Zhou; Chen-Chen Liu; Jian-Bo Gao
Journal:  World J Gastroenterol       Date:  2022-08-21       Impact factor: 5.374

4.  Dual-Layer Spectral CT Imaging of Upper Aerodigestive Tract Cancer: Analysis of Spectral Imaging Parameters and Impact on Tumor Staging.

Authors:  C C-T Hsu; C Jeavon; I Fomin; L Du; C Buchan; T W Watkins; Y Nae; N M Parry; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-29       Impact factor: 4.966

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.